T. Qi

发表

GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder Carcinoma

Yu Long, Peihua Liu, Qixin Zhang, 2022, Frontiers in Surgery.

Identification of non-small cell lung cancer (NSCLC) patients who benefit from treatment beyond progression with pembrolizumab from individual lesion response dynamics

Timothy Qi, T. Qi, Y. Cao, 2022, medRxiv.

An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts

Hao Deng, Zhi Liu, D. Deng, 2023, Frontiers in Genetics.

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer

X. Zu, Zhi Liu, Z. Ou, 2021, Frontiers in Immunology.

A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer

X. Zu, Qiao Tang, Zhi Liu, 2021, Frontiers in Immunology.

A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts

Yuanqing Dai, Huihuang Li, N. Liu, 2023, Frontiers in Pharmacology.

ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts

Jinhui Liu, Yuanqing Dai, D. Deng, 2023, Frontiers in Genetics.

ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts

Bo-long Liu, D. Deng, T. Qi, 2023, Frontiers in Pharmacology.